title: Impact of commonly used transplant immunosuppressive drugs on human NK cell function is dependent upon stimulation condition.
abstract: Lung transplantation is a recognised treatment for patients with end stage pulmonary disease. Transplant recipients receive life-long administration of immunosuppressive drugs that target T cell mediated graft rejection. However little is known of the impact on NK cells, which have the potential to be alloreactive in response to HLA-mismatched ligands on the lung allograft and in doing so, may impact negatively on allograft survival. NK cells from 20 healthy controls were assessed in response to Cyclosporine A, Mycophenolic acid (MPA; active form of Mycophenolate mofetil) and Prednisolone at a range of concentrations. The impact of these clinically used immunosuppressive drugs on cytotoxicity (measured by CD107a expression), IFN-γ production and CFSE proliferation was assessed in response to various stimuli including MHC class-I negative cell lines, IL-2/IL-12 cytokines and PMA/Ionomycin. Treatment with MPA and Prednisolone revealed significantly reduced CD107a expression in response to cell line stimulation. In comparison, addition of MPA and Cyclosporine A displayed reduced CD107a expression and IFN-γ production following PMA/Ionomycin stimulation. Diminished proliferation was observed in response to treatment with each drug. Additional functional inhibitors (LY294002, PD98059, Rottlerin, Rapamycin) were used to elucidate intracellular pathways of NK cell activation in response to stimulation with K562 or PMA-I. CD107a expression was significantly decreased with the addition of PD98059 following K562 stimulation. Similarly, CD107a expression significantly decreased following PMA-I stimulation with the addition of LY294002, PD98059 and Rottlerin. Ten lung transplant patients, not receiving immunosuppressive drugs pre-transplant, were assessed for longitudinal changes post-transplant in relation to the administration of immunosuppressive drugs. Individual patient dynamics revealed different longitudinal patterns of NK cell function post-transplantation. These results provide mechanistic insights into pathways of NK cell activation and show commonly administered transplant immunosuppression agents and clinical rejection/infection events have differential effects on NK cell function that may impact the immune response following lung transplantation.
authors.affiliation: Department of Medicine, Monash University, Melbourne, Victoria, Australia.
authors.forename: Aislin C
authors.initials: AC
authors.lastname: Meehan
authors.forename: Nicole A
authors.initials: NA
authors.lastname: Mifsud
authors.forename: Thi H O
authors.initials: TH
authors.lastname: Nguyen
authors.forename: Bronwyn J
authors.initials: BJ
authors.lastname: Levvey
authors.forename: Greg I
authors.initials: GI
authors.lastname: Snell
authors.forename: Tom C
authors.initials: TC
authors.lastname: Kotsimbos
authors.forename: Glen P
authors.initials: GP
authors.lastname: Westall
mesh_terms: D000098:Acetophenones / Q000494:pharmacology; D000328:Adult; D001578:Benzopyrans / Q000494:pharmacology; D002478:Cells, Cultured; D002867:Chromones / Q000494:pharmacology; D016572:Cyclosporine / Q000494:pharmacology; D005260:Female; D005419:Flavonoids / Q000494:pharmacology; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D007371:Interferon-gamma / Q000378:metabolism; D007694:Killer Cells, Natural / Q000187:drug effects* / Q000378:metabolism; D016040:Lung Transplantation; D052118:Lysosomal-Associated Membrane Protein 1 / Q000378:metabolism; D008297:Male; D009025:Morpholines / Q000494:pharmacology; D009173:Mycophenolic Acid / Q000494:pharmacology; D011239:Prednisolone / Q000494:pharmacology
chemical_list: D000098:Acetophenones; D001578:Benzopyrans; D002867:Chromones; D005419:Flavonoids; D007166:Immunosuppressive Agents; D052118:Lysosomal-Associated Membrane Protein 1; D009025:Morpholines; C085911:2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one; D007371:Interferon-gamma; D016572:Cyclosporine; D011239:Prednisolone; C085746:rottlerin; D009173:Mycophenolic Acid; C093973:2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one
references.citation: Transplantation. 2008 Jan 15;85(1):145-9
references.pmid: 18192925
references.citation: J Immunol Methods. 2011 Jul 29;370(1-2):86-92
references.pmid: 21689658
references.citation: Hum Gene Ther. 2011 Dec;22(12):1587-91
references.pmid: 21732766
references.citation: Semin Thorac Cardiovasc Surg. 2004 Winter;16(4):333-41
references.pmid: 15635537
references.citation: J Am Soc Nephrol. 1999 Jun;10(6):1366-80
references.pmid: 10361877
references.citation: Transpl Int. 2009 Sep;22(9):859-68
references.pmid: 19386078
references.citation: PLoS One. 2010 Oct 12;5(10):e13294
references.pmid: 20967261
references.citation: Clin Exp Immunol. 2003 Apr;132(1):96-104
references.pmid: 12653843
references.citation: Blood. 2007 May 1;109(9):3767-75
references.pmid: 17234744
references.citation: J Immunol Methods. 2003 Dec;283(1-2):99-114
references.pmid: 14659903
references.citation: Nat Rev Immunol. 2005 Mar;5(3):201-14
references.pmid: 15719024
references.citation: Transplantation. 1983 Feb;35(2):127-9
references.pmid: 6829073
references.citation: Am J Reprod Immunol. 2008 Mar;59(3):259-65
references.pmid: 18275519
references.citation: J Heart Lung Transplant. 2006 May;25(5):557-63
references.pmid: 16678035
references.citation: J Heart Lung Transplant. 2008 Sep;27(9):995-1001
references.pmid: 18765192
references.citation: Eur J Immunol. 2004 Nov;34(11):3028-38
references.pmid: 15368269
references.citation: J Heart Lung Transplant. 2007 Dec;26(12):1229-42
references.pmid: 18096473
references.citation: J Pharmacol Exp Ther. 1999 Dec;291(3):1100-12
references.pmid: 10565830
references.citation: Transplantation. 1981 Feb;31(2):113-6
references.pmid: 7256824
references.citation: J Heart Lung Transplant. 2008 Feb;27(2):203-7
references.pmid: 18267228
references.citation: Adv Exp Med Biol. 2005;560:57-61
references.pmid: 15932020
references.citation: Science. 2002 Mar 15;295(5562):2097-100
references.pmid: 11896281
references.citation: Blood. 2007 Sep 1;110(5):1530-9
references.pmid: 17495133
references.citation: J Immunol. 2009 May 15;182(10):6267-77
references.pmid: 19414780
references.citation: Trends Immunol. 2001 Nov;22(11):633-40
references.pmid: 11698225
references.citation: J Immunol Methods. 2004 Nov;294(1-2):15-22
references.pmid: 15604012
references.citation: Clin Biochem. 1998 Jul;31(5):309-16
references.pmid: 9721427
references.citation: Transplantation. 1991 Jan;51(1):268-70
references.pmid: 1702910
references.citation: Clin Diagn Lab Immunol. 2001 Mar;8(2):303-13
references.pmid: 11238213
references.citation: Am J Transplant. 2010 Sep;10(9):1981-90
references.pmid: 20883533
references.citation: Am J Transplant. 2010 Jun;10(6):1354-8
references.pmid: 20353480
references.citation: J Autoimmun. 2008 Aug;31(1):7-12
references.pmid: 18442895
references.citation: Transpl Immunol. 2008 Apr;19(1):1-11
references.pmid: 18346631
references.citation: Transplantation. 1997 Apr 27;63(8):1138-44
references.pmid: 9133476
references.citation: Transplantation. 2010 Mar 27;89(6):756-63
references.pmid: 20019647
references.citation: Expert Opin Pharmacother. 2003 Dec;4(12):2325-45
references.pmid: 14640931
references.citation: Science. 1992 Oct 23;258(5082):607-14
references.pmid: 1411571
references.citation: Transplantation. 2006 Oct 27;82(8):1004-12
references.pmid: 17060847